With more widespread use of whole-exome sequencing (WES), the ability to study the genetic basis for rare disorders like very early onset inflammatory bowel disease (VEO-IBD) has improved considerably. A recent study (JR Kelsen et al. Gastroenterol 2015; 149: 1415-24) analyzed 125 patients (3 weeks to 4 years of age) and compared with pediatric IBD patients (n=45), adult-onset Crohn’s (n=20), and healthy controls (n=145). Link to abstract and online material. (Link includes full-text as well).
The authors focused their study on 400 genes/regions associated with primary immunodeficiency.
- “Our analysis showed novel and rare variants within these genes that could contribute to the development of VEO-IBD, including rare heterozygous missense variants in IL10RA and previously unidentified variants in MSH5 and CD19.”
In their discussion, the authors elaborate on these findings. In addition, in Table 3, the authors elaborate on potential immunologic studies for these children.
Take home message: The authors recommend “a more complete immunologic evaluation be performed in patients with VEO-IBD.” Ultimately, understanding the complex genetics will lead to more individualized and successful treatments.
Related blog posts:
Pingback: Expanding VEO Variants | gutsandgrowth
Pingback: Patterns and Puzzles with Very Early Onset Inflammatory Bowel Disease | gutsandgrowth
Pingback: More IBD Cases Than Ever in Young Canadian Children | gutsandgrowth